Table 1.
Demographic characteristics of the study participants.
| Demographic Characteristics | Total Sample N = 200 (%) | Atlantic Node N = 32 (%) | British Columbia Node N = 32 (%) | Ontario Node N = 67 (%) | Prairies Node N = 38 (%) | Quebec Node N = 31 (%) |
|---|---|---|---|---|---|---|
| Age (years, mean ± SD) | 41.2 ± 11.1 | 34.4 ± 9.8 | 42.4 ± 10.5 | 41.5 ± 11.8 | 41.6 ± 11.0 | 45.5 ± 8.8 |
| Age Groups | ||||||
| 18–30 | 38 (19.0) | 12 (37.5) | 5 (15.6) | 13 (19.4) | 6 (15.8) | 2 (6.5) |
| 31–45 | 90 (45.0) | 17 (53.1) | 14 (43.8) | 29 (43.3) | 18 (47.4) | 12 (38.7) |
| 46–64 | 70 (35.0) | 3 (9.4) | 12 (37.5) | 24 (35.8) | 14 (36.8) | 17 (54.8) |
| ≥ 65 | 2 (1.0) | 0 | 1 (3.1) | 1 (1.5) | 0 | 0 |
| Gender | ||||||
| Male | 112 (56.0) | 21 (65.6) | 16 (50.0) | 36 (53.7) | 19 (50.0) | 20 (64.5) |
| Female | 81 (40.5) | 10 (31.3) | 15 (46.9) | 27 (40.3) | 18 (47.4) | 11 (35.5) |
| Othera | 7 (3.5) | 1 (3.1) | 1 (3.1) | 4 (6.0) | 1 (2.6) | 0 |
| Ethnicity | ||||||
| Caucasian | 118 (59.0) | 24 (75.0) | 17 (53.1) | 41 (61.2) | 16 (42.1) | 20 (64.5) |
| Indigenous | 58 (29.0) | 7 (21.9) | 14 (43.8) | 14 (20.9) | 21 (55.3) | 2 (6.5) |
| Other | 24 (12.0) | 1 (3.1) | 1 (3.1) | 12 (17.9) | 1 (2.6) | 9 (29.0) |
| Opioid Agonist Therapy | ||||||
| No | 128 (64.0) | 17 (53.1) | 15 (46.9) | 48 (71.6) | 32 (84.2) | 16 (51.6) |
| Yes | 72 (36.0) | 15 (46.9) | 17 (53.1) | 19 (28.4) | 6 (15.8) | 15 (48.4) |
| Methadone | 49 (68.1) | 8 (53.3) | 12 (70.6) | 15 (79.0) | 1 (16.7) | 13 (86.7) |
| Suboxone | 12 (16.7) | 7 (46.7) | 2 (11.8) | 2 (10.5) | 0 | 1 (6.7) |
| Other | 11 (15.3) | 0 | 3 (17.7) | 2 (10.5) | 5 (83.3) | 1 (6.7) |
| Living Situation | ||||||
| Housed | 149 (74.5) | 20 (62.5) | 13 (40.6) | 55 (82.1) | 33 (86.8) | 28 (90.3) |
| Transient | 18 (9.0) | 7 (21.9) | 4 (12.5) | 3 (4.5) | 1 (2.6) | 3 (9.7) |
| Shelter | 13 (6.5) | 4 (12.5) | 3 (9.4) | 6 (9.0) | 0 | 0 |
| Homeless/Street | 20 (10.0) | 1 (3.1) | 12 (37.5) | 3 (4.5) | 4 (10.5) | 0 |
a
Transgender/Non-binary.